Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® Compared to SYMBICORT® TURBOHALER®
Study Title
- Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAXֲ® as Compared to SYMBICORTֲ® TURBOHALERֲ® as Treatment for Adult Patients With Asthma
Teva Identifier
- BFS-AS-40035 | 2013-004630-14
ClinicalTrials.gov Identifier
- NCT02062463
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 75 Years
Trial Duration
- 06/01/2014 - 04/01/2015
Phase
- Phase 4
Study Type
Interventional
